Cancer screening tests, cancer diagnoses during COVID-19 pandemic
What The Study Did:
The number of patients undergoing cancer screening tests and of subsequent cancer diagnoses during the COVID-19 pandemic in the largest health care system in the northeastern United States was assessed in this study.
Toni K. Choueiri, M.D., of the Dana-Farber Cancer Institute and Quoc-Dien Trinh, M.D., of Brigham and Women’s Hospital in Boston, are the corresponding authors.
To access the embargoed study:
Visit our For The Media website at this link
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article
This link will be live at the embargo time
JAMA Network Media Relations